Benign Female Reproductive System Neoplasm Clinical Trial
Official title:
Does Less Trendelenburg Make a Difference in Robotic Assisted Gynecological Procedures?
Verified date | January 2018 |
Source | Advocate Health Care |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patient/Population: Women over the age of 18, who are not pregnant and are undergoing benign,
robotic-assisted gynecologic procedures at Lutheran General Hospital.
Intervention: Decreasing the angle of Trendelenburg for the procedure Control: Steep
Trendelenburg, which is the usual standard of care, to the limit of the operative bed, which
is 30 degrees.
Outcome: Outcomes will include the mean angle of Trendelenburg in the experimental arm and
the difference in Trendelenburg between the two arms. Additional outcomes included will be
end tidal Carbon dioxide, peak airway pressure, mean arterial pressure, heart rate and
arterial Carbon dioxide. Secondary outcomes will include operative time, blood loss and
conversion to laparotomy.
Status | Terminated |
Enrollment | 22 |
Est. completion date | July 20, 2016 |
Est. primary completion date | July 20, 2016 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - all women at Lutheran General Hospital undergoing robotic-assisted benign gynecologic procedures and who agree to participate in the study. - Women who are 18 years or older on the day of surgery. - Patients with any co-morbidity or prior surgery, as long as they are cleared by their surgeon and anesthesia to undergo robotic-assisted surgery. Exclusion Criteria: - pregnant women - Anyone who is less than 18 years old on the day of surgery. - Anyone who does not have the capacity to make independent medical decisions. |
Country | Name | City | State |
---|---|---|---|
United States | Advocate Lutheran General Hospital | Park Ridge | Illinois |
Lead Sponsor | Collaborator |
---|---|
Advocate Health Care |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | • Mean Angle of Trendelenburg during surgery (Degrees of the operative head down, measured by electronic angle meter) and the difference in the two arms | Measured using electronic Angle Meter from supine to Trendelenburg in degrees (0-30) | 0-240 minutes | |
Secondary | Cardiovascular Outcomes- Heart rate | Heart rate (beats per minute) measured in beats per minute by anesthesiologist at the beginning of the case prior to insufflation, after insufflation, every 30 minutes while in Trendelenburg and at the end of the case. | 0-240 minutes | |
Secondary | Respiratory Parameter- arterial CO2 | Arterial CO2- Measured by taking an arterial blood gas from the arterial line by the anesthesiologist at the beginning of the case prior to insufflation, and then every hour while in Trendelenburg. | 0-240 minutes | |
Secondary | Respiratory Outcomes- End Tidal CO2 | End Tidal CO2 measured in mmHg by anesthesiologist at the beginning of the case prior to insufflation, after insufflation, every 30 minutes while in Trendelenburg and then at the end of the case. | 0-240 minutes | |
Secondary | Respiratory Outcomes- Peak Airway Pressure | Peak Airway Pressure (mm Hg) measured in mmHg by anesthesiologist at the beginning of the case prior to insufflation, after insufflation, every 30 minutes while in Trendelenburg and then at the end of the case. | 0-240 minutes | |
Secondary | Cardiovascular Outcomes- Mean arterial Pressure | Mean arterial pressure (mm hg) measured in mmHg by anesthesiologist at the beginning of the case prior to insufflation, after insufflation, every 30 minutes while in Trendelenburg and then at the end of the case. | 0-240 minutes | |
Secondary | Operative Time | The operative time will be measured (minutes) from the time the robot was docked until it is undocked. | 1-240 minutes | |
Secondary | Estimated Blood Loss | The blood loss (mL) will be measured by subtracting the irrigation fluid used from the fluid suctioned out during the procedure. | 0-240 minutes | |
Secondary | Redocking of the robot | It will be recorded whether the robot required undocking, placement in greater Trendelenburg and redocking of the robot in order to complete the procedure. | 0-240 minutes | |
Secondary | Conversion of surgical approach | It will be recorded whether the surgical approach was transitioned to traditional laparoscopy or laparotomy versus a robotic-assisted procedure as scheduled. | 0-240 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01566669 -
Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic Surgery
|
N/A |